Table 6

Characteristics of symptomatic and asymptomatic patients

SymptomaticAsymptomatic
AbnormalNormalAbnormalNormal
No of patients2313168
Benzodiazepine receptor index (%)
 MCA territory (affected)41.1±36.425.9±32.823.4±19.123.4±22.6
 ACA territory21.2±19.0*11.0±16.816.0±13.49.4±11.3
Cerebral blood flow (ml/100 g/min)
 MCA territory40.3±7.044.1±9.345.8±7.846.7±8.3
 ACA territory43.2±8.146.0±10.148.1±8.549.4±11.4
Cerebral metabolic rate of oxygen (ml/100 g/min)
 MCA territory3.61±0.383.61±0.343.55±0.494.10±0.55
 ACA territory3.74±0.403.60±0.363.63±0.414.29±0.72
Age (years)65±962±1166±660±8
Sex, male/female (n)14/910/314/27/1
Arterial disease, internal carotid artery/MCA (n)15/88/513/37/1
Side of disease, left/right (n)11/126/78/83/5
Subcortical infarction (n)231282
 Size (mm2)197±225182±20452±9076±211
 Frontal infarction (n)161050
Wisconsin Card Sorting Test parameters (n)
 Categories achieved1.7±0.9*4.3±1.10.8±0.9*4.7±1.0
 Total errors28.2±8.6*16.4±4.529.2±5.1*15.1±3.7
 Perseverative errors (Nelson)12.4±9.9*3.6±3.49.2±4.2*3.3±2.3
  • Values are mean±SD.

  • * p<0.05, Mann–Whitney U test.

  • Abnormal, low categories achieved on the Wisconsin Card Sorting Test; ACA, anterior cerebral artery; MCA, middle cerebral artery.